Edition:
United States

Vetoquinol SA (VETO.PA)

VETO.PA on Paris Stock Exchange

48.00EUR
25 Jul 2017
Change (% chg)

€0.50 (+1.05%)
Prev Close
€47.50
Open
€47.81
Day's High
€48.00
Day's Low
€47.81
Volume
61
Avg. Vol
3,146
52-wk High
€54.44
52-wk Low
€38.23

VETO.PA

Chart for VETO.PA

About

Vetoquinol SA is a France-based company that specializes in the research, development, manufacture, marketing and sale of veterinary drugs and products. The Company’s product portfolio is divided between livestock, such as cattle and pigs, and companion animals, including dogs and cats. Vetoquinol SA’s offering includes... (more)

Overall

Beta: 0.12
Market Cap(Mil.): €572.11
Shares Outstanding(Mil.): 11.88
Dividend: 0.43
Yield (%): 0.89

Financials

  VETO.PA Industry Sector
P/E (TTM): 20.51 11.79 15.85
EPS (TTM): 2.35 -- --
ROI: 8.16 -10.04 -8.31
ROE: 9.19 -9.89 -7.95

BRIEF-Vetoquinol Q1 2017 sales stable at 86.1 million euros

* Consolidated sales for Q1 2017 amounted to 86.1 million euros ($91.5 million), up 0.4 percent as reported from same period last year Source text for Eikon: Further company coverage: ($1 = 0.9408 euros) (Gdynia Newsroom)

Apr 13 2017

BRIEF-Vetoquinol FY EBITDA rises to 56.1 million euros

* FY EBITDA 56.1 million euros ($60.65 million) versus 50.9 million euros year ago

Mar 22 2017

BRIEF-Vetoquinol 2016 sales of 350.3 million euros, 4.3% like-for-like growth

* 2016 Sales: 350.3 million euros ($373.70 million), 4.3 pct like-for-like growth

Jan 26 2017

Earnings vs. Estimates